The FDA’s Paxlovid Pandemonium
SHARE | PRINT | EMAIL
Not only was evidence of failure deliberately ignored; prospective testing methodologies were altered mid-trial to favor a positive outcome when it became appar... Read more.
Dr. David Gortler is a pharmacologist, pharmacist, research scientist and a former member of the FDA Senior Executive Leadership Team who served as senior advisor to the FDA Commissioner on matters of: FDA regulatory affairs, drug safety and FDA science policy. He is a former Yale University and Georgetown University didactic professor of pharmacology and biotechnology, with over a decade of academic pedagogy and bench research, as part of his nearly two decades of experience in drug development. He also serves as a scholar at the Ethics and Public Policy Center and a 2023 Brownstone Fellow.